Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Buy
10,212
+1,733
+20% +$224K 0.01% 903
2026
Q1
$1.08M Buy
8,479
+485
+6% +$73.3K 0.01% 1010
2025
Q4
$1.2M Buy
7,994
+1,061
+15% +$150K 0.01% 972
2025
Q3
$974K Sell
6,933
-329
-5% -$45K 0.01% 1070
2025
Q2
$873K Buy
7,262
+2,274
+46% +$254K 0.01% 1108
2025
Q1
$610K Buy
4,988
+4
+0.1% +$506 0.01% 1238
2024
Q4
$634K Buy
4,984
+167
+3% +$19.3K 0.01% 1204
2024
Q3
$475K Sell
4,817
-356
-7% -$32.9K 0.01% 1355
2024
Q2
$491K Buy
+5,173
New +$488K 0.01% 1309

Other funds holding JBTM

Atria Investments's JBTM Position: Q2 2026 in Review

Atria Investments increased its JBT Marel (JBTM) stake by 20% in Q2 2026, buying an estimated $224K and bringing the position to 10,212 shares worth $1.48M. The position accounts for 0.01% of the portfolio, ranked #903.

Atria Investments first reported a position in JBTM in Q2 2024 and has held it in 9 quarters since. 390 funds tracked by Wall St. Rank hold JBTM as of Q2 2026.

  • Atria Investments held 10,212 shares of JBT Marel worth $1.48M as of Q2 2026.
  • Atria Investments bought 1,733 JBT Marel shares in Q2 2026, an estimated $224K.
  • JBT Marel made up 0.01% of Atria Investments's portfolio in Q2 2026, its #903 holding.
  • Atria Investments first reported a position in JBT Marel in Q2 2024 and has held it in 9 quarters since.
  • 390 funds tracked by Wall St. Rank held JBT Marel as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.